NYSE:ALB - Albemarle Stock Price, Price Target & More

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Tuesday, May 8th. Stockholders of record on Friday, June 15th will be paid a dividend of $0.335 per share on Monday, July 2nd. This represents a $1.34 annualized dividend and a dividend yield of 1.41%. The ex-dividend date is Thursday, June 14th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) released its earnings results on Wednesday, May, 9th. The specialty chemicals company reported $1.30 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.20 by $0.10. The specialty chemicals company had revenue of $821.60 million for the quarter, compared to analyst estimates of $798.20 million. Albemarle had a net margin of 4.27% and a return on equity of 13.80%. The company's revenue for the quarter was up 13.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.05 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Albemarle.

Albemarle issued an update on its FY18 earnings guidance on Wednesday, May, 9th. The company provided EPS guidance of $5.10-5.40 for the period, compared to the Thomson Reuters consensus estimate of $5.17. The company issued revenue guidance of $3.2-3.4 billion, compared to the consensus revenue estimate of $3.30 billion.

22 equities research analysts have issued twelve-month target prices for Albemarle's shares. Their predictions range from $106.00 to $157.00. On average, they anticipate Albemarle's stock price to reach $132.0255 in the next year. This suggests a possible upside of 39.0% from the stock's current price. View Analyst Ratings for Albemarle.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 hold ratings and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Albemarle include Eastman Chemical (EMN), Sinopec Shanghai Petrochemical Co. ADR Class H (SHI), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A Schulman (SHLM), AdvanSix (ASIX), ForceField Energy (FNRG) and Cereplast (CERPQ).

News articles about ALB stock have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Albemarle earned a media sentiment score of 0.09 on Accern's scale. They also gave media headlines about the specialty chemicals company an impact score of 47.00 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Albemarle's stock is owned by a variety of of institutional and retail investors. Top institutional investors include KAMES CAPITAL plc (0.47%), Handelsbanken Fonder AB (0.23%), Scout Investments Inc. (0.12%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%), State of Alaska Department of Revenue (0.02%) and Regent Investment Management LLC (0.02%). Company insiders that own Albemarle stock include Douglas L Maine, John Sherman Jr, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Fjarde AP Fonden Fourth Swedish National Pension Fund and State of Alaska Department of Revenue. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Matthew Juneau. View Insider Buying and Selling for Albemarle.

ALB stock was acquired by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Scout Investments Inc., KAMES CAPITAL plc, Capital Asset Advisory Services LLC, IFM Investors Pty Ltd, DnB Asset Management AS and Regent Investment Management LLC. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $94.96.

Albemarle has a market capitalization of $10.59 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.